Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$24.15 - $31.95 $1.06 Million - $1.4 Million
-43,731 Reduced 73.59%
15,693 $456,000
Q4 2023

Jan 31, 2024

BUY
$18.07 - $29.37 $547,683 - $890,175
30,309 Added 104.1%
59,424 $1.64 Million
Q3 2023

Nov 01, 2023

BUY
$22.41 - $41.99 $15,507 - $29,057
692 Added 2.43%
29,115 $652,000
Q2 2023

Jul 31, 2023

BUY
$40.4 - $59.1 $2,464 - $3,605
61 Added 0.22%
28,423 $1.16 Million
Q1 2023

May 01, 2023

BUY
$38.16 - $48.86 $8,318 - $10,651
218 Added 0.77%
28,362 $1.37 Million
Q4 2022

Jan 31, 2023

SELL
$33.53 - $54.79 $14,116 - $23,066
-421 Reduced 1.47%
28,144 $1.07 Million
Q3 2022

Nov 10, 2022

BUY
$41.85 - $53.85 $145,972 - $187,828
3,488 Added 13.91%
28,565 $1.43 Million
Q2 2022

Aug 12, 2022

BUY
$25.6 - $45.23 $2,560 - $4,523
100 Added 0.4%
25,077 $1.01 Million
Q1 2022

May 16, 2022

BUY
$33.33 - $44.6 $10,665 - $14,272
320 Added 1.3%
24,977 $932,000
Q4 2021

Feb 11, 2022

BUY
$35.36 - $41.86 $15,452 - $18,292
437 Added 1.8%
24,657 $982,000
Q3 2021

Nov 10, 2021

BUY
$37.01 - $44.74 $9,067 - $10,961
245 Added 1.02%
24,220 $901,000
Q2 2021

Aug 12, 2021

BUY
$37.95 - $49.37 $3,149 - $4,097
83 Added 0.35%
23,975 $1.01 Million
Q1 2021

May 17, 2021

SELL
$46.8 - $68.92 $14,367 - $21,158
-307 Reduced 1.27%
23,892 $1.13 Million
Q4 2020

Feb 16, 2021

SELL
$47.96 - $67.64 $1,055 - $1,488
-22 Reduced 0.09%
24,199 $1.48 Million
Q3 2020

Nov 13, 2020

SELL
$45.41 - $57.07 $163,021 - $204,881
-3,590 Reduced 12.91%
24,221 $1.13 Million
Q2 2020

Aug 14, 2020

BUY
$42.56 - $54.98 $142,448 - $184,018
3,347 Added 13.68%
27,811 $1.41 Million
Q1 2020

May 15, 2020

SELL
$32.37 - $59.36 $440,782 - $808,305
-13,617 Reduced 35.76%
24,464 $1.09 Million
Q4 2019

Feb 14, 2020

BUY
$32.22 - $50.07 $1.23 Million - $1.91 Million
38,081 New
38,081 $1.83 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.